Laboratory Corp. of America Holdings | Income Statement

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
5,808
6,012
8,680
9,642
10,441
11,333
Cost of Goods Sold (COGS) incl. D&A
3,667
3,885
5,941
6,641
7,194
8,389
Gross Income
2,142
2,126
2,739
3,001
3,248
2,945
SG&A Expense
1,129
1,175
1,463
1,599
1,742
1,507
EBIT
1,013
952
-
1,402
1,505
1,438
Unusual Expense
22
43
334
95
141
112
Non Operating Income/Expense
2
10
6
3
8
168
Interest Expense
97
108
222
214
235
244
Pretax Income
916
827
726
1,106
1,135
1,268
Income Tax
340
314
287
372
139
384
Consolidated Net Income
575
513
439
733
1,274
884
Net Income
574
511
438
732
1,268
884
Net Income After Extraordinaries
574
511
438
732
1,268
884
Net Income Available to Common
574
511
438
732
1,268
884
EPS (Basic)
6.25
5.92
4.35
7.02
12.21
8.61
Basic Shares Outstanding
90
85
99
103
102
101
EPS (Diluted)
6.25
5.92
4.35
7.02
12.21
8.61
Diluted Shares Outstanding
92
86
101
104
104
103
EBITDA
1,239
1,186
1,711
1,892
2,039
1,990
Non-Operating Interest Income
2
1
2
2
2
8
Minority Interest Expense
2
1
1
1
6
-
Equity in Affiliates (Pretax)
17
14
10
8
11
12

About Laboratory

View Profile
Address
358 South Main Street
Burlington North Carolina 27215
United States
Employees -
Website http://www.labcorp.com
Updated 07/08/2019
Laboratory Corp. of America Holdings is a clinical laboratory company, which engages in the provision of clinical laboratory and end-to-end drug development services. It operates through the LabCorp Diagnostics and Covance Drug Development segments. The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing.